Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health It Prescription Routing topic
No spam. Unsubscribe anytime.
Commission approves Photon Health as a prescription intermediary, citing HIPAA and integration questions
Summary
The commission approved Photon Health (presented as ‘Photon’/Photon Health) as an intermediary that routes prescriptions and notifies patients, subject to integration and data‑security conditions discussed in the meeting.
The Connecticut Commission of Pharmacy voted to approve Photon Health (presented at the meeting as Photon) as an intermediary service that can route prescriptions and provide patient notifications. The board emphasized that Photon must be HIPAA‑compliant and noted the company’s SOC 2 compliance and penetration testing claims as presented.
Presenter Emily Howe (pharmacist background) described Photon’s model: prescriptions written in an integrated prescriber workflow generate a patient notification allowing the patient to select a pharmacy; the platform provides status updates and aims to increase transparency about pharmacy services, stock, insurance network status and office hours. Commissioners asked whether the technology would steer patients, whether pharmacies could pay for preferential placement, and how Photon would know if a pharmacy in the system actually had a medication on hand. Howe said the platform does not steer prescriptions for payment and that inventory/status availability depends on software integrations with pharmacy systems; for nonintegrated pharmacies the company described manual calls as a stopgap.
The board discussed technical and policy points—how prior claims might be trapped in limbo at a pharmacy, the need for connectivity to third‑party plan networks to determine in‑network status, and whether Photon would integrate with widely used EHRs. Board members raised patient‑safety questions about prescriptions routed to closed pharmacies and whether claims could be reversed; Photon said deeper integration with pharmacy systems and payers would be required to address these cases.
Why it matters: the approval expands the number of intermediaries that can receive and route electronic prescriptions and represents a regulatory decision about new technology providers that interface between prescribers, patients and pharmacies.
Ending: The commission approved Photon Health on a motion and voice vote; staff recorded the approval and will monitor integrations and compliance with privacy and security requirements.
